BRIEF published on 04/03/2025 at 13:24, 1 year 4 months ago Innate Pharma participe au Stifel 2025 Virtual Targeted Oncology Forum Euronext Paris Immunothérapie Oncologie Innate Pharma Forum Virtuel
BRIEF published on 04/03/2025 at 13:24, 1 year 4 months ago Innate Pharma participates in the Stifel 2025 Virtual Targeted Oncology Forum Euronext Paris Oncology Immunotherapy Innate Pharma Virtual Forum
PRESS RELEASE published on 04/03/2025 at 13:19, 1 year 4 months ago INFORMATIONS PRIVILÉGIÉES / AUTRES COMMUNIQUÉS Innate Pharma annonce sa participation au Stifel 2025 Virtual Targeted Oncology Forum. Présentation prévue le 9 avril 2025. Informations sur les traitements innovants contre le cancer Immunothérapie Cancer Oncologie Innate Pharma Stifel 2025
BRIEF published on 04/03/2025 at 13:18, 1 year 4 months ago Innate Pharma to Engage in Stifel 2025 Virtual Oncology Forum Biotechnology Immunotherapy Virtual Event Innate Pharma Oncology Forum 2025
BRIEF published on 04/03/2025 at 13:18, 1 year 4 months ago Innate Pharma participera au forum virtuel d'oncologie Stifel 2025 Biotechnologie Immunothérapie Événement Virtuel Innate Pharma Forum D'oncologie 2025
PRESS RELEASE published on 04/03/2025 at 13:13, 1 year 4 months ago INSIDE INFORMATION / OTHER NEWS RELEASES Innate Pharma to participate in 2025 Stifel Virtual Targeted Oncology Forum. Executive team presenting and hosting 1x1 meetings. Focus on innovative cancer immunotherapies Cancer Innate Pharma Immunothérapies Stifel Targeted Oncology Forum
PRESS RELEASE published on 03/28/2025 at 14:37, 1 year 4 months ago Annual financial and audit reports / Annual financial report
PRESS RELEASE published on 03/28/2025 at 14:32, 1 year 4 months ago Rapports financiers et d'audit annuels / Rapport financier annuel
BRIEF published on 03/20/2025 at 07:05, 1 year 4 months ago Innate Pharma annonce une conférence sur les résultats financiers 2024 Résultats Financiers Conférence Téléphonique Cotation Boursière Innate Pharma Immunothérapie Cancer
BRIEF published on 03/20/2025 at 07:05, 1 year 4 months ago Innate Pharma Announces 2024 Financial Results Conference Financial Results Conference Call Stock Market Listing Cancer Immunotherapy Innate Pharma
Published on 08/11/2026 at 12:10, 31 minutes ago CoTec Holdings Corp. Announces $20m Private Placement Of Unsecured Convertible Debentures
Published on 08/11/2026 at 12:00, 41 minutes ago Bitterroot Resources Ltd. - Update on the LM Nickel-Copper Project, Michigan, USA
Published on 08/11/2026 at 12:00, 41 minutes ago Zomedica Announces "Fourth Friday at Four" Webinar on August 28, 2026: Zomedica International: Building a Global Platform for Veterinary Innovation
Published on 08/11/2026 at 07:00, 5 hours 41 minutes ago Alaska Energy Metals Announces Closing of Shares for Debt Settlement
Published on 08/11/2026 at 00:40, 12 hours 1 minute ago CORRECTION FROM SOURCE: Fermi Announces Binding Lease Agreement with TensorWave
Published on 08/11/2026 at 12:30, 11 minutes ago Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Published on 08/11/2026 at 12:05, 35 minutes ago Cambrex Milan Celebrates 80th Anniversary with Construction of New $30 Million R&D Facility
Published on 08/11/2026 at 12:00, 41 minutes ago Iute Advances Its Digital Banking Platform with iuteMarket
Published on 08/11/2026 at 11:13, 1 hour 27 minutes ago Barrick neighbour, Lake Victoria Gold, announces initial resource estimate for the Tembo gold project
Published on 08/10/2026 at 18:00, 18 hours 41 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 18 hours 41 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 18 hours 56 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 08/10/2026 at 11:53, 1 day ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
